Get startedLog in
    Picture of Bharat Parenterals logo

    541096 — Bharat Parenterals Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Bharat Parenterals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue2,0462,1202,1802,5743,404
    Cost of Revenue
    Gross Profit6256726878441,155
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Other Operating Expenses
    Total Operating Expenses1,8541,9042,0382,4333,720
    Operating Profit193216142141-316
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes271279236187-340
    Provision for Income Taxes
    Net Income After Taxes203208158105-437
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income204211164145-126
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income204211164145-126
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS35.637.627.825-18.3
    Dividends per Share